Article Figures & Data
Figures
- Figure 1
- Participants’ responses regarding the side effects of antidepressant and the most likely associated agent. *Others include antidepressants listed in the Massachusetts General Hospital Psychopharmacology questionnaire but were not mentioned in the table.
Tables
- Table 1
- Participants’ choice of preferred antidepressant agents in various clinical scenarios and depression subtypes.
Clinical scenario or depression subtype Preferred agent (%) Anxious depression SSRIs (64.1) Depression with prominent insomnia Mirtazapine (75.0) Depression with atypical features MAOIs (42.3) Depression with melancholic features SSRIs (39.7) MAOIs - Monaoamine Oxidase Inhibitors, SSRIs - Selective Serotonin Reuptake Inhibitors
Peterson's study results (percentage of participants' preference of antidepressant treatment) Evidence (APA Guidelines 2000, revised) Efficacy SSRIs (48%) No difference Sexual dysfunction Fluoxetine (56%) More common with paroxetine Agitation Fluoxetine (52%) Comparable to other SSRIs Discontinuation syndrome Paroxetine (47%) Occurs among short half-life antidepressants Atypical depression SSRIs (57%) MAOIs Melancholic depression SSRIs (57%) No specific recommendation, (pharmacotherapy and ECT leads to good responses) APA - American Psychiatric Association, ECT - electric shock treatment, MAOIs - Monaoamine Oxidase Inhibitors, SSRIs - Selective Serotonin Reuptake Inhibitors
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.